Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa sustained effects study in symptomatic neurogenic orthostatic hypotension
2013-005118-36Phase 3Terminated
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Neurogenic Orthostatic Hypotension (nOH) comparing droxidopa with placebo (2 arms). Primary endpoint: Relative mean change in OHSA Item #1 from randomization to Week 1. Started May 2014; status: terminated.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on 2013-005118-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005118-36.